+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Azelnidipine Market by Dosage (Controlled Release, Immediate Release), Application (Hypertension, Renal Protection), Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 197 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968280
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Azelnidipine Market grew from USD 509.23 million in 2023 to USD 535.56 million in 2024. It is expected to continue growing at a CAGR of 5.28%, reaching USD 730.10 million by 2030.

This mechanism contributes to the dilation of arterial vessels, leading to reduced blood pressure. Major factors driving the expansion of its use include its long-acting nature, which supports better patient compliance, and its minimal impact on the renin-angiotensin system, making it a suitable option for patients with renal and cardiac conditions. However, Azelnidipine may present disadvantages, such as the potential side effects of peripheral edema, dizziness, palpitations, and development complexity. Addressing these concerns involves patient education on potential side effects, monitoring patient responses closely, and adjusting dosages or co-prescribing with complimentary medications to mitigate adverse effects. Market players are working on formulation improvements of azelnidipine for enhanced patient tolerance, exploration of its efficacy in combination therapies, and potential applications beyond hypertension based on its vascular protective properties. As the global burden of hypertension increases, the need for effective and tolerable treatments, including azelnidipine, is expected to rise, underlining the importance of ongoing research and development efforts to maximize its therapeutic potential.

Regional Insights

In the APAC region, countries such as Japan and China witness a higher consumption of Azelnidipine, which is attributed to its approval and widespread acceptance among healthcare professionals. Japan, being one of the initial markets for Azelnidipine, has a robust manufacturing setup with companies focusing on innovation to cater to domestic needs and potential export markets. Chinese and Indian pharmaceutical companies are ramping up production capabilities, leveraging lower manufacturing costs to increase market share both locally and globally. In the Americas, azelnidipine’s usage is limited due to the presence of a wide array of alternative hypertension treatments. The production is mainly dominated by large pharmaceutical companies that adhere to the stringent regulations set forth by the FDA. However, companies are increasingly focusing on research and development to expand its use. European countries show moderate levels of use, with stringent regulatory approvals influencing the market presence of Azelnidipine. Companies in this region are deeply involved in clinical trials aiming to diversify the applications of Azelnidipine, which could spur its usage across Europe. The Middle East and Africa are at a nascent stage concerning the adoption of Azelnidipine, with multinational pharmaceutical companies navigating regulatory and market entry challenges to establish a foothold.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Azelnidipine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing prevalence of hypertension among global population
  • Initiatives promoting hypertension awareness and early treatment

Market Restraints

  • Complex approval and development of azelnidipine

Market Opportunities

  • Ongoing R&D about azelnidipine in the medical industry
  • Efforts by pharmaceutical companies for the marketing of azelnidipine

Market Challenges

  • Potential side effects of azelnidipine on health

Market Segmentation Analysis

  • Dosage: Expanding preference for controlled-release azelnidipine medications
  • Application: Emerging potential of azelnidipine to treat hypertension

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Azelnidipine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Azelnidipine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

India’s CDSCO Gives Nod to Akum Pharmaceuticals to Manufacture & Market CVS FDC

Akum Pharmaceuticals received approval from the Subject Expert Committee (SEC) under the auspices of the Central Drug Standard Control Organisation (CDSCO) to manufacture and distribute a novel fixed-dose combination (FDC) of two cardiovascular medications, azelnidipine and metoprolol succinate presented in a state-of-the-art film-coated, bi-layered tablet form. This notable endorsement follows a thorough examination of the Phase III clinical trial data by the SEC, specifically concerning its efficacy in addressing hypertension. The unique blend offered in this FDC operates by dilating blood vessels and lessening the heart's workload, thereby efficiently managing high blood pressure. This advancement represents a significant stride in cardiovascular healthcare, potentially setting a new standard for hypertension treatment strategies.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Azelnidipine Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Azelnidipine Market, highlighting leading vendors and their innovative profiles. These include Adooq Bioscience LLC., Anant Pharmaceuticals Pvt. Ltd., Arran Chemical Company Ltd. by Almac Group, BioCrick BioTech, Cayman Chemical, Clearsynth, Daiichi-Sankyo Company, Limited., Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., Jeil Pharmaceutical Co., Ltd., Kimia Biosciences Ltd, LKT Laboratories, Inc., Manus Aktteva Biopharma LLP, Merck KGaA, Parchem Fine and Specialty Chemicals, Inc., Selleck Chemicals LLC, Steris Pharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Thermo Fisher Scientific, Inc., Tokyo Chemical Industry Co., Ltd., and UBE Corporation.

Market Segmentation & Coverage

This research report categorizes the Azelnidipine Market to forecast the revenues and analyze trends in each of the following sub-markets:

Dosage

  • Controlled Release
  • Immediate Release

Application

  • Hypertension
  • Renal Protection

Distribution Channel

  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of hypertension among global population
5.1.1.2. Initiatives promoting hypertension awareness and early treatment
5.1.2. Restraints
5.1.2.1. Complex approval and development of azelnidipine
5.1.3. Opportunities
5.1.3.1. Ongoing R&D about azelnidipine in the medical industry
5.1.3.2. Efforts by pharmaceutical companies for the marketing of azelnidipine
5.1.4. Challenges
5.1.4.1. Potential side effects of azelnidipine on health
5.2. Market Segmentation Analysis
5.2.1. Dosage: Expanding preference for controlled-release azelnidipine medications
5.2.2. Application: Emerging potential of azelnidipine to treat hypertension
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Azelnidipine Market, by Dosage
6.1. Introduction
6.2. Controlled Release
6.3. Immediate Release
7. Azelnidipine Market, by Application
7.1. Introduction
7.2. Hypertension
7.3. Renal Protection
8. Azelnidipine Market, by Distribution Channel
8.1. Introduction
8.2. Hospitals
8.3. Online Pharmacies
8.4. Retail Pharmacies
9. Americas Azelnidipine Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Azelnidipine Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Azelnidipine Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. India’s CDSCO Gives Nod to Akum Pharmaceuticals to Manufacture & Market CVS FDC
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. AZELNIDIPINE MARKET RESEARCH PROCESS
FIGURE 2. AZELNIDIPINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL AZELNIDIPINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL AZELNIDIPINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL AZELNIDIPINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. AZELNIDIPINE MARKET DYNAMICS
FIGURE 7. GLOBAL AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. GLOBAL AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES AZELNIDIPINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES AZELNIDIPINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. AZELNIDIPINE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. AZELNIDIPINE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. AZELNIDIPINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL AZELNIDIPINE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL AZELNIDIPINE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL AZELNIDIPINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL AZELNIDIPINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL AZELNIDIPINE MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL AZELNIDIPINE MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL AZELNIDIPINE MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL AZELNIDIPINE MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL AZELNIDIPINE MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL AZELNIDIPINE MARKET SIZE, BY HYPERTENSION, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL AZELNIDIPINE MARKET SIZE, BY RENAL PROTECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL AZELNIDIPINE MARKET SIZE, BY RENAL PROTECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL AZELNIDIPINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL AZELNIDIPINE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL AZELNIDIPINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL AZELNIDIPINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. AMERICAS AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 28. AMERICAS AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 35. ARGENTINA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 36. ARGENTINA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 41. BRAZIL AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 42. BRAZIL AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 47. CANADA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 48. CANADA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 49. CANADA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. CANADA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. CANADA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 52. CANADA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 53. MEXICO AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 54. MEXICO AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 55. MEXICO AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. MEXICO AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. MEXICO AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 58. MEXICO AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 59. UNITED STATES AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 60. UNITED STATES AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES AZELNIDIPINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES AZELNIDIPINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 68. ASIA-PACIFIC AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 75. AUSTRALIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 76. AUSTRALIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 81. CHINA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 82. CHINA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 83. CHINA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. CHINA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. CHINA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 86. CHINA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 87. INDIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 88. INDIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 89. INDIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. INDIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. INDIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 92. INDIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 93. INDONESIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 94. INDONESIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 99. JAPAN AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 100. JAPAN AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 101. JAPAN AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. JAPAN AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. JAPAN AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 104. JAPAN AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 105. MALAYSIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 106. MALAYSIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 111. PHILIPPINES AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 112. PHILIPPINES AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 117. SINGAPORE AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 118. SINGAPORE AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 123. SOUTH KOREA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 124. SOUTH KOREA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 129. TAIWAN AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 130. TAIWAN AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 135. THAILAND AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 136. THAILAND AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 137. THAILAND AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. THAILAND AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. THAILAND AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 140. THAILAND AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 141. VIETNAM AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 142. VIETNAM AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA AZELNIDIPINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 155. DENMARK AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 156. DENMARK AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 157. DENMARK AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. DENMARK AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. DENMARK AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 160. DENMARK AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 161. EGYPT AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 162. EGYPT AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 163. EGYPT AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. EGYPT AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. EGYPT AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 166. EGYPT AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 167. FINLAND AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 168. FINLAND AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 169. FINLAND AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. FINLAND AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. FINLAND AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 172. FINLAND AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 173. FRANCE AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 174. FRANCE AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 175. FRANCE AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. FRANCE AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. FRANCE AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 178. FRANCE AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 179. GERMANY AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 180. GERMANY AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 181. GERMANY AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. GERMANY AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. GERMANY AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 184. GERMANY AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 185. ISRAEL AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 186. ISRAEL AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 191. ITALY AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 192. ITALY AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 193. ITALY AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. ITALY AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. ITALY AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 196. ITALY AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 197. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 198. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 203. NIGERIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 204. NIGERIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 209. NORWAY AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 210. NORWAY AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 211. NORWAY AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. NORWAY AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. NORWAY AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 214. NORWAY AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 215. POLAND AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 216. POLAND AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 217. POLAND AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. POLAND AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. POLAND AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 220. POLAND AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 221. QATAR AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 222. QATAR AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 223. QATAR AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. QATAR AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. QATAR AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 226. QATAR AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 227. RUSSIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 228. RUSSIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 234. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 240. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 245. SPAIN AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 246. SPAIN AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 247. SPAIN AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. SPAIN AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SPAIN AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 250. SPAIN AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 251. SWEDEN AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 252. SWEDEN AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 257. SWITZERLAND AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 258. SWITZERLAND AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 263. TURKEY AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 264. TURKEY AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 265. TURKEY AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. TURKEY AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. TURKEY AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 268. TURKEY AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2018-2023 (USD MILLION)
TABLE 276. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY DOSAGE, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM AZELNIDIPINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 281. AZELNIDIPINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 282. AZELNIDIPINE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Adooq Bioscience LLC.
  • Anant Pharmaceuticals Pvt. Ltd.
  • Arran Chemical Company Ltd. by Almac Group
  • BioCrick BioTech
  • Cayman Chemical
  • Clearsynth
  • Daiichi-Sankyo Company, Limited.
  • Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
  • Jeil Pharmaceutical Co. , Ltd.
  • Kimia Biosciences Ltd
  • LKT Laboratories, Inc.
  • Manus Aktteva Biopharma LLP
  • Merck KGaA
  • Parchem Fine and Specialty Chemicals, Inc.
  • Selleck Chemicals LLC
  • Steris Pharma Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific, Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • UBE Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 535.56 Million
Forecasted Market Value ( USD ) by 2030 $ 730.1 Million
Compound Annual Growth Rate5.2%
Regions CoveredGlobal

Related Topics

Related Reports

Azelnidipine (CAS 123524-52-7) Global Market Research Report 2024 - Product Image

Azelnidipine (CAS 123524-52-7) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Global Colchicine Market by Dosage Formulation (Liquid, Semisolid Gel, Solid), Age (Adult, Children, Senior), Route of Administration, Sales Channels, Application - Forecast 2024-2030 - Product Image

Global Colchicine Market by Dosage Formulation (Liquid, Semisolid Gel, Solid), Age (Adult, Children, Senior), Route of Administration, Sales Channels, Application - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Global Bivalirudin Market by Dosage Form (Injection, Powder), Application (Angioplasty, Heparin-induced Thrombocytopenia, Percutaneous Coronary Intervention), End-Use - Forecast 2024-2030 - Product Image

Global Bivalirudin Market by Dosage Form (Injection, Powder), Application (Angioplasty, Heparin-induced Thrombocytopenia, Percutaneous Coronary Intervention), End-Use - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Polypill Products - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Polypill Products - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 105 Pages
  • Global
From
Global Anti-hypertensive Drugs Market Size, Share & Trends Analysis Report by Drug Class (Diuretics, ACE Inhibitors), Type (Primary, Secondary), Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Anti-hypertensive Drugs Market Size, Share & Trends Analysis Report by Drug Class (Diuretics, ACE Inhibitors), Type (Primary, Secondary), Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 180 Pages
  • Global
From

About the Azelnidipine Market

Azelnidipine is a calcium channel blocker used to treat hypertension and angina pectoris. It is a dihydropyridine derivative and is classified as a third-generation calcium channel blocker. It is used to reduce blood pressure and improve blood flow to the heart. It works by blocking the entry of calcium into the cells of the heart and blood vessels, which helps to relax the blood vessels and reduce blood pressure. Azelnidipine is available in both oral and intravenous formulations. It is marketed under various brand names, including Azelnidipine, Azelnidipine-H, Azelnidipine-L, and Azelnidipine-XL. It is available in various strengths and formulations, including tablets, capsules, and oral solutions. Azelnidipine is used in combination with other drugs to treat hypertension and angina pectoris. It is also used to reduce the risk of stroke and heart attack in patients with coronary artery disease. The azelnidipine market is highly competitive, with several major players operating in the space. Some of the key players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.